Advisor Group
GCVRZ

Advisor Group’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Advisor Group’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$3K Buy
4,178
+114
+3% +$88 ﹤0.01% 4938
2019
Q3 		$2K Buy
4,064
+2
+0% +$1 ﹤0.01% 5059
2019
Q2 		$2K Sell
4,062
-500
-11% -$250 ﹤0.01% 5051
2019
Q1 		$2K Sell
4,562
-740
-14% -$345 ﹤0.01% 5009
2018
Q4 		$3K Buy
5,302
+295
+6% +$147 ﹤0.01% 4781
2018
Q3 		$3K Buy
5,007
+51
+1% +$27 ﹤0.01% 4803
2018
Q2 		$3K Sell
4,956
-21
-0.4% -$10 ﹤0.01% 4624
2018
Q1 		$2K Sell
4,977
-50
-1% -$20 ﹤0.01% 4772
2017
Q4 		$2K Buy
5,027
+64
+1% +$24 ﹤0.01% 4777
2017
Q3 		$2K Hold
4,963
– – ﹤0.01% 4641
2017
Q2 		$2K Buy
4,963
+7
+0.1% +$3 ﹤0.01% 4599
2017
Q1 		$3K Buy
4,956
+40
+0.8% +$18 ﹤0.01% 4353
2016
Q4 		$2K Buy
4,916
+3,474
+241% +$1.18K ﹤0.01% 4318
2016
Q3 		$0 Buy
1,442
+740
+105% +$187 ﹤0.01% 4881
2016
Q2 		$0 Buy
+702
New +$121 ﹤0.01% 4675

Other funds holding GCVRZ

SCM
Stonehill Capital Management New York $350M AUM 73.6% 1-Year Est. Return
Elliott Management
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
MCM
Mason Capital Management New York $607M AUM 1.77% 1-Year Est. Return
TPG Group Holdings (SBS) Advisors
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Brigade Capital Management
Brigade Capital Management New York $534M AUM 44.37% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Whitebox Advisors
Whitebox Advisors Minneapolis, Minnesota $7.65B AUM 13.87% 1-Year Est. Return
NGA
New Generation Advisors Manchester, Massachusetts $45.6M AUM 15.43% 1-Year Est. Return
Highbridge Capital Management
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return

Advisor Group's GCVRZ Position: Q4 2019 in Review

Advisor Group increased its Sanofi Contingent Value Rights (GCVRZ) stake by 2.8% in Q4 2019, buying an estimated $88 and bringing the position to 4,178 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #4938.

Advisor Group first reported a position in GCVRZ in Q2 2016 and has held it in 15 quarters since. 103 funds tracked by Wall St. Rank hold GCVRZ as of Q4 2019.

  • Advisor Group held 4,178 shares of Sanofi Contingent Value Rights worth $3K as of Q4 2019.
  • Advisor Group bought 114 Sanofi Contingent Value Rights shares in Q4 2019, an estimated $88.
  • Sanofi Contingent Value Rights made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4938 holding.
  • Advisor Group first reported a position in Sanofi Contingent Value Rights in Q2 2016 and has held it in 15 quarters since.
  • 103 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.